Literature DB >> 633405

Carcinogenicity of vinyl chloride and vinylidene chloride.

C C Lee, J C Bhandari, J M Winston, W B House, R L Dixon, J S Woods.   

Abstract

Exposure of mice to 50, 250, or 1000 ppmm of vinyl chloride (VC) in the air for 6 h/d, 5 d/wk, caused a high incidence of bronchioloalveolar adenoma, mammary gland tumors, and hemangiosarcoma. Mammary gland tumors occurred in the females and included ductular adenocarcinoma and squamous and anaplastic cell carcinomas with metastasis to the lung. Hemangiosarcoma occurred in the liver and, to a lesser extent, in various other organs. The incidence and severity of these tumors increased with the concentration of VC and the length of exposure. Malignant lymphoma involving various organs was observed in several mice. Rats were more resistant to the carcinogenic effects of VC. Exposure of rats to 250 or 1000 ppm of VC caused hemangiosarcoma in the liver. Many rats with hepatic hemangiosarcoma also developed hemangiosarcoma in the lung. Extrahepatic hemangiosarcoma also occasionally occurred in other organs. Exposure to 55 ppm of vinylidene chloride (VDC) caused hepatic hemangiosarcoma and probably bronchioloalveolar adenoma in mice. Hemangiosarcoma also occurred in the mesenteric lymph node or subcutaneous tissue in two rats exposed to 55 ppm of VDC.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 633405     DOI: 10.1080/15287397809529640

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  11 in total

1.  Reactions of vinyl chloride with RNA and DNA of various mouse tissues in vivo.

Authors:  K Bergman
Journal:  Arch Toxicol       Date:  1982-01       Impact factor: 5.153

2.  Renal Cell Carcinomas in Vinylidene Chloride-exposed Male B6C3F1 Mice Are Characterized by Oxidative Stress and TP53 Pathway Dysregulation.

Authors:  Schantel A Hayes; Arun R Pandiri; Thai-vu T Ton; Hue-Hua L Hong; Natasha P Clayton; Keith R Shockley; Shyamal D Peddada; Kevin Gerrish; Michael Wyde; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2015-12-17       Impact factor: 1.902

3.  Monooxygenase activity and ultrastructural changes of liver in the course of chronic exposure of rats to vinyl chloride.

Authors:  J M Wiśniewska-Knypl; J Klimczak; J Kołakowski
Journal:  Int Arch Occup Environ Health       Date:  1980       Impact factor: 3.015

4.  Hepatic angiosarcoma. Animal model: angiosarcoma of rats and mice induced by vinyl chloride.

Authors:  C B Hong; J M Winston; C C Lee
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

5.  Identification of potential carcinogens in technical grade 1,1,1-trichloroethane.

Authors:  D Henschler; D Reichert; M Metzler
Journal:  Int Arch Occup Environ Health       Date:  1980       Impact factor: 3.015

6.  Interactive toxicity and stress protein expression by vinylidene chloride and monochloroacetate in precision-cut rat liver slices.

Authors:  J Wijeweera; J Gandolfi; X H Zheng
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

Review 7.  Vinyl chloride: still a cause for concern.

Authors:  J Kielhorn; C Melber; U Wahnschaffe; A Aitio; I Mangelsdorf
Journal:  Environ Health Perspect       Date:  2000-07       Impact factor: 9.031

8.  Cancer induction following single and multiple exposures to a constant amount of vinyl chloride monomer.

Authors:  R M Hehir; B P McNamara; J McLaughlin; D A Willigan; G Bierbower; J F Hardisty
Journal:  Environ Health Perspect       Date:  1981-10       Impact factor: 9.031

9.  Cell specificity in DNA binding and repair of chemical carcinogens.

Authors:  J A Swenberg; D E Rickert; B L Baranyi; J I Goodman
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

10.  A carcinogenic potency database of the standardized results of animal bioassays.

Authors:  L S Gold; C B Sawyer; R Magaw; G M Backman; M de Veciana; R Levinson; N K Hooper; W R Havender; L Bernstein; R Peto
Journal:  Environ Health Perspect       Date:  1984-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.